Abstract: The present invention relates to a combination of a curcuminoid and a taxane for use in the treatment of a hormone-refractory prostate cancer (HRPC) in a patient in need thereof.
Type:
Application
Filed:
April 27, 2012
Publication date:
May 22, 2014
Applicants:
CENTRE JEAN PERRIN, Institut National de la Sante et de la Recherche Medicale (INSERM), UNIVERSITE D'AUVERGNE CLERMONT